Detalles de la búsqueda
1.
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Br J Haematol
; 196(4): 892-901, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34761389
2.
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study.
J Clin Immunol
; 42(5): 923-934, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35420363
3.
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
Lancet
; 395(10241): 1919-1926, 2020 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32473682
4.
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
Lancet Oncol
; 21(10): 1309-1316, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32853557
5.
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19.
JAMA Netw Open
; 5(2): e220130, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35188551
6.
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
Front Immunol
; 13: 912571, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35720400
Resultados
1 -
6
de 6
1
Próxima >
>>